Trial Radar
Sign in

NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Screen2Prevent (S2P)
Screen2Prevent (S2P)

NCT07728123

RecruitingNA

Sponsor: Westat

Conditions: HIV Infections

Interventions: HIV screening strategies

Countries: United States

Screen2Prevent is a study intended to improve HIV prevention and detection through implementation and evaluation of three different broad-scale HIV screening approaches a) targeted, b) universally offered opt-in, and c) universally offered opt-out in Emergency Departments (EDs) by leveraging digital health to identify and link adolescents seeking care in the ED to HIV Pre-Exposure Prophylaxis (PrEP)/Antiretroviral treatment (ART).

Eligibility overview

Sex: ALL

Age: 14 Years to 24 Years

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* Age 14-24 years, inclusive
* Present to the participating ED, regardless of chief complaint during the study period

Exclusion Criteria:

* None
Locations (5)
  • Tampa, Florida, United States
  • Atlanta, Georgia, United States
  • Baltimore, Maryland, United States
  • Memphis, Tennessee, United States
  • Houston, Texas, United States